Obserwuj
Linda M. Pilarski
Linda M. Pilarski
Professor, Dept Oncology, University of Alberta and Cross Cancer Institute
Zweryfikowany adres z ualberta.ca
Tytuł
Cytowane przez
Cytowane przez
Rok
International Myeloma Working Group molecular classification of multiple myeloma: spotlight review
R Fonseca, PL Bergsagel, J Drach, J Shaughnessy, N Gutierrez, ...
Leukemia 23 (12), 2210-2221, 2009
12192009
Risk of progression and survival in multiple myeloma relapsing after therapy with IMiDs and bortezomib: a multicenter international myeloma working group study
SK Kumar, JH Lee, JJ Lahuerta, G Morgan, PG Richardson, J Crowley, ...
Leukemia 26 (1), 149-157, 2012
9862012
Genetics and cytogenetics of multiple myeloma: a workshop report
R Fonseca, B Barlogie, R Bataille, C Bastard, PL Bergsagel, M Chesi, ...
Cancer research 64 (4), 1546-1558, 2004
9492004
In multiple myeloma, t (4; 14)(p16; q32) is an adverse prognostic factor irrespective of FGFR3 expression
JJ Keats, T Reiman, CA Maxwell, BJ Taylor, LM Larratt, MJ Mant, ...
Blood, The Journal of the American Society of Hematology 101 (4), 1520-1529, 2003
5122003
International Myeloma Working Group recommendations for the diagnosis and management of myeloma-related renal impairment
MA Dimopoulos, P Sonneveld, N Leung, G Merlini, H Ludwig, E Kastritis, ...
Journal of Clinical Oncology 34 (13), 1544-1557, 2016
4702016
In Vitro and in Vivo Targeting of Immunoliposomal Doxorubicin to Human B-Cell Lymphoma
DE Lopes de Menezes, LM Pilarski, TM Allen
Cancer research 58 (15), 3320-3330, 1998
4261998
Management of relapsed multiple myeloma: recommendations of the International Myeloma Working Group
J Laubach, L Garderet, A Mahindra, G Gahrton, J Caers, O Sezer, ...
Leukemia 30 (5), 1005-1017, 2016
3072016
The breast mucin MUC1 as a novel adhesion ligand for endothelial intercellular adhesion molecule 1 in breast cancer
LH Regimbald, LM Pilarski, BM Longenecker, MA Reddish, ...
Cancer research 56 (18), 4244-4249, 1996
2951996
Loss of CD45R (Lp220) represents a post-thymic T cell differentiation event.
HM Serra, JF Krowka, JA Ledbetter, LM Pilarski
Journal of immunology (Baltimore, Md.: 1950) 140 (5), 1435-1441, 1988
2681988
RHAMM is a centrosomal protein that interacts with dynein and maintains spindle pole stability
CA Maxwell, JJ Keats, M Crainie, X Sun, T Yen, E Shibuya, M Hendzel, ...
Molecular biology of the cell 14 (6), 2262-2276, 2003
2512003
In multiple myeloma, clonotypic B lymphocytes are detectable among CD19+ peripheral blood cells expressing CD38, CD56, and monotypic Ig light chain [published erratum appears …
PL Bergsagel, AM Smith, A Szczepek, MJ Mant, AR Belch, LM Pilarski
2281995
Hyaluronan and hyaluronan synthases: potential therapeutic targets in cancer
S Adamia, CA Maxwell, LM Pilarski
Current Drug Targets-Cardiovascular & Hematological Disorders 5 (1), 3-14, 2005
2222005
Overexpression of transcripts originating from the MMSET locus characterizes all t (4; 14)(p16; q32)-positive multiple myeloma patients
JJ Keats, CA Maxwell, BJ Taylor, MJ Hendzel, M Chesi, PL Bergsagel, ...
Blood 105 (10), 4060-4069, 2005
2092005
A combined dielectrophoresis, traveling wave dielectrophoresis and electrorotation microchip for the manipulation and characterization of human malignant cells
EG Cen, C Dalton, Y Li, S Adamia, LM Pilarski, KVIS Kaler
Journal of microbiological methods 58 (3), 387-401, 2004
1902004
Myeloma progenitors in the blood of patients with aggressive or minimal disease: engraftment and self-renewal of primary human myeloma in the bone marrow of NOD SCID mice
LM Pilarski, G Hipperson, K Seeberger, E Pruski, RW Coupland, ...
Blood, The Journal of the American Society of Hematology 95 (3), 1056-1065, 2000
1792000
A high frequency of circulating B cells share clonotypic Ig heavy-chain VDJ rearrangements with autologous bone marrow plasma cells in multiple myeloma, as measured by single …
AJ Szczepek, K Seeberger, J Wizniak, MJ Mant, AR Belch, LM Pilarski
Blood, The Journal of the American Society of Hematology 92 (8), 2844-2855, 1998
1781998
CD20-directed serotherapy in patients with multiple myeloma: biologic considerations and therapeutic applications
SP Treon, LM Pilarski, AR Belch, A Kelliher, FI Preffer, Y Shima, ...
Journal of immunotherapy 25 (1), 72-81, 2002
1752002
A requirement for antigen-specific helper T cells in the generation of cytotoxic T cells from thymocyte precursors.
LM Pilarski
The Journal of experimental medicine 145 (3), 709-725, 1977
1681977
Muc-1 core protein is expressed on multiple myeloma cells and is induced by dexamethasone
SP Treon, JA Mollick, M Urashima, G Teoh, D Chauhan, A Ogata, N Raje, ...
Blood, The Journal of the American Society of Hematology 93 (4), 1287-1298, 1999
1671999
Monoclonal circulating B cells in multiple myeloma: a continuously differentiating, possibly invasive, population as defined by expression of CD45 isoforms and adhesion molecules
LM Pilarski, GS Jensen
Hematology/oncology clinics of North America 6 (2), 297-322, 1992
1671992
Nie można teraz wykonać tej operacji. Spróbuj ponownie później.
Prace 1–20